ImmunityBio,

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunityBio, and other ETFs, options, and stocks.

About IBRX

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. 

CEO
Richard Adcock
CEORichard Adcock
Employees
680
Employees680
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
680
Employees680

IBRX Key Statistics

Market cap
2.20B
Market cap2.20B
Price-Earnings ratio
-4.26
Price-Earnings ratio-4.26
Dividend yield
Dividend yield
Average volume
13.68M
Average volume13.68M
High today
$2.59
High today$2.59
Low today
$2.39
Low today$2.39
Open price
$2.50
Open price$2.50
Volume
9.77M
Volume9.77M
52 Week high
$8.69
52 Week high$8.69
52 Week low
$1.83
52 Week low$1.83

People also own

Based on the portfolios of people who own IBRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.